{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:23:52Z","timestamp":1767705832204,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011962","name":"Research Center for Infectious Diseases and Tropical Medicine, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["62957"],"award-info":[{"award-number":["62957"]}],"id":[{"id":"10.13039\/100011962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.diagmicrobio.2024.116229","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T19:48:49Z","timestamp":1708631329000},"page":"116229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains"],"prefix":"10.1016","volume":"109","author":[{"given":"Roghayeh","family":"Nouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kourosh Masnadi","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Yeganeh","family":"Sefiadn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba Naeimi","family":"Mazraeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Sattarpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ahangarzadeh","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116229_bib0001","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","article-title":"Colorectal cancer epidemiology: recent trends and impact on outcomes","volume":"22","author":"Baidoun","year":"2021","journal-title":"Curr Drug Targets"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116229_bib0002","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol Rev\/Przegl\u0105d Gastroenterol."},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-022-04192-w","article-title":"The role of gut microbiota in the development of colorectal cancer: a review","volume":"37","author":"Koyande","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-cancerbio-070120-095211","article-title":"Gut microbiota in colorectal cancer: associations, mechanisms, and clinical approaches","volume":"6","author":"Pleguezuelos-Manzano","year":"2022","journal-title":"Annu Rev Cancer Biol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116229_bib0005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/jgh.15077","article-title":"Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions","volume":"35","author":"Gao","year":"2020","journal-title":"J Gastroenterol Hep"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116229_bib0006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/biomedicines8110489","article-title":"Gut microbiota and colorectal cancer development: a closer look to the adenoma-carcinoma sequence","volume":"8","author":"Vacante","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116229_bib0007","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000508328","article-title":"Gut microbiota dysbiosis drives the development of colorectal cancer","volume":"102","author":"Fan","year":"2021","journal-title":"Digestion"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2014.00019","article-title":"What is the future of the gut microbiota-related treatment? Toward modulation of microbiota in preventive and therapeutic medicine","volume":"1","author":"Zatorski","year":"2014","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116229_bib0009","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.gendis.2016.03.004","article-title":"Gut microbiota, inflammation and colorectal cancer","volume":"3","author":"Sun","year":"2016","journal-title":"Genes Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0010","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116229_bib0011","doi-asserted-by":"crossref","first-page":"e16393","DOI":"10.1371\/journal.pone.0016393","article-title":"Microbial dysbiosis in colorectal cancer (CRC) patients","volume":"6","author":"Sobhani","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116229_bib0012","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/cancers11101592","article-title":"Targeting programmed Fusobacterium nucleatum Fap2 for colorectal cancer therapy","volume":"11","author":"Ganesan","year":"2019","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116229_bib0013","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1128\/IAI.70.8.4302-4311.2002","article-title":"Identification of an aggregative adhesion fimbria (AAF) type III-encoding operon in enteroaggregative Escherichia coli as a sensitive probe for detecting the AAF-encoding operon family","volume":"70","author":"Bernier","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116229_bib0014","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the Human Gut by E. coli and Colorectal Cancer RiskColonization of Human Gut by E. coli and Colorectal Cancer","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.diagmicrobio.2024.116229_bib0015","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3748\/wjg.v20.i21.6560","article-title":"Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation","volume":"20","author":"Raisch","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116229_bib0016","doi-asserted-by":"crossref","first-page":"e56964","DOI":"10.1371\/journal.pone.0056964","article-title":"High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer","volume":"8","author":"Buc","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116229_bib0017","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/labinvest.2014.161","article-title":"Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression","volume":"95","author":"Raisch","year":"2015","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116229_bib0018","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the human gut by E. coli and colorectal cancer risk","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116229_bib0019","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1099\/mic.0.2007\/013086-0","article-title":"A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli","volume":"154","author":"Bronowski","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijsu.2015.04.077","article-title":"Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study","volume":"18","author":"Magdy","year":"2015","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116229_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2004.03.054","article-title":"Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer","volume":"127","author":"Martin","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/165637","article-title":"Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia","volume":"2009","author":"Lim","year":"2009","journal-title":"J Biotechnol Biomed"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116229_bib0023","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1128\/JCM.38.5.2001-2004.2000","article-title":"Multiplex PCRs for identification of Escherichia coli virulence genes","volume":"38","author":"Pass","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijfoodmicro.2013.03.020","article-title":"Prevalence and antibiotic resistance profiles of diarrheagenic Escherichia coli strains isolated from food items in northwestern Mexico","volume":"164","author":"Canizalez-Roman","year":"2013","journal-title":"Int J Food Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116229_bib0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1574-6968.2010.02160.x","article-title":"Prevalence of Escherichia coli among samples collected from the genital tract in pregnant and nonpregnant women: relationship with virulence","volume":"11","author":"Guiral","year":"2011","journal-title":"FEMS Microbiol Lett"},{"issue":"1-2","key":"10.1016\/j.diagmicrobio.2024.116229_bib0026","first-page":"17","article-title":"Prevalence and evaluation of toxin genes among uropathogenic Escherichia coli clinical isolates by duplex PCR","volume":"1","author":"Saraylu","year":"2012","journal-title":"J Med Microbiol Bacteriol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116229_bib0027","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/JCM.02365-09","article-title":"Cyclomodulins in urosepsis strains of Escherichia coli","volume":"48","author":"Dubois","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116229_bib0028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1758-2229.12019","article-title":"The C lermont E scherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups","volume":"5","author":"Clermont","year":"2013","journal-title":"Environ Microbiol Rep"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104233","article-title":"Virulence determinants and genetic diversity of adherent-invasive Escherichia coli (AIEC) strains isolated from patients with Crohn's disease","volume":"145","author":"Abdelhalim","year":"2020","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116229_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25522-6","article-title":"Processive dynamics of the usher assembly platform during uropathogenic Escherichia coli P pilus biogenesis","volume":"12","author":"Du","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0031","first-page":"1","article-title":"Adaptive strategies of uropathogenic Escherichia coli CFT073: from growth in lab media to virulence during host cell adhesion","author":"Sarshar","year":"2022","journal-title":"I Int Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116229_bib0032","first-page":"52","article-title":"Determination of virulence determinants of Escherichia coli strains isolated from patients with colorectal cancer compared to the healthy subjects","volume":"12","author":"Zarei","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116229_bib0033","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1136\/gutjnl-2013-306099","article-title":"\u03b1-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon","volume":"63","author":"B\u00fccker","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.diagmicrobio.2024.116229_bib0034","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5009\/gnl220260","article-title":"Microbial metabolite dysbiosis and colorectal cancer","volume":"17","author":"Niekamp","year":"2023","journal-title":"Gut Liver"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116229_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213529","article-title":"The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence","volume":"14","author":"Messina","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116229_bib0036","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/1389201022666210910094827","article-title":"Escherichia coli and colorectal cancer: unfolding the enigmatic relationship","volume":"23","author":"Nouri","year":"2022","journal-title":"Curr Pharm Biotechnol"},{"issue":"21","key":"10.1016\/j.diagmicrobio.2024.116229_bib0037","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1007\/s00253-017-8507-y","article-title":"The role of major virulence factors of AIEC involved in inflammatory bowl disease\u2014a mini-review","volume":"101","author":"Yang","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116229_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05513-1","article-title":"A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T09:07:06Z","timestamp":1714208826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0732889324000580"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116229","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116229"}}